Implications of recombinant erythropoietin therapy for renal transplantation - PubMed (original) (raw)

. 1990:10 Suppl 2:44-7; discussion 48-52.

doi: 10.1159/000168217.

Affiliations

• PMID: 2260618
• DOI: 10.1159/000168217

Implications of recombinant erythropoietin therapy for renal transplantation

H J Ward. Am J Nephrol. 1990.

Abstract

We previously reported on the efficiency by which endogenous erythropoietin production corrects anemia after successful renal transplantation. Recent clinical experience with recombinant human erythropoietin in renal failure has demonstrated major benefit in correcting anemia with few adverse consequences. This article reviews our experience to date with recombinant human erythropoietin use in transplant recipients and explores the impact of therapy for the dialysis population awaiting transplantation. The issues of ongoing need for pretransplant blood transfusion, presensitization, organ transplant demand, therapeutic use of human recombinant erythropoietin for chronic rejection, and impact of an expanding, high-quality transplant recipient pool are discussed in the context of the recombinant erythropoietin era.

PubMed Disclaimer

Similar articles

• Recombinant human erythropoietin in renal transplant recipients with renal anemia.
  Traindl O, Barnas U, Franz M, Falger S, Klauser R, Kovarik J, Graf H. Traindl O, et al. Clin Transplant. 1994 Feb;8(1):45-8. Clin Transplant. 1994. PMID: 8136567
• Anemia treatment with erythropoietin in pregnant renal recipients.
  Cyganek A, Pietrzak B, Kociszewska-Najman B, Sanko-Resmer J, Paczek L, Wielgos M. Cyganek A, et al. Transplant Proc. 2011 Oct;43(8):2970-2. doi: 10.1016/j.transproceed.2011.08.054. Transplant Proc. 2011. PMID: 21996203
• The impact of recombinant human erythropoietin therapy on renal transplantation.
  Ettenger RB, Marik J, Grimm P. Ettenger RB, et al. Am J Kidney Dis. 1991 Oct;18(4 Suppl 1):57-61. Am J Kidney Dis. 1991. PMID: 1928081
• Erythropoietin and renal transplantation.
  Muirhead N. Muirhead N. Kidney Int Suppl. 1999 Mar;69:S86-92. doi: 10.1046/j.1523-1755.1999.055suppl.69086.x. Kidney Int Suppl. 1999. PMID: 10084292 Review.
• Erythropoiesis and erythropoietin levels in renal transplant recipients.
  Wolff M, Jelkmann W. Wolff M, et al. Klin Wochenschr. 1991 Jan 22;69(2):53-8. doi: 10.1007/BF01666817. Klin Wochenschr. 1991. PMID: 2027270 Review.

Cited by

• Recombinant human erythropoietin versus placebo or no treatment for the anaemia of chronic kidney disease in people not requiring dialysis.
  Cody JD, Hodson EM. Cody JD, et al. Cochrane Database Syst Rev. 2016 Jan 20;2016(1):CD003266. doi: 10.1002/14651858.CD003266.pub3. Cochrane Database Syst Rev. 2016. PMID: 26790135 Free PMC article. Review.
• Androgens for the anaemia of chronic kidney disease in adults.
  Yang Q, Abudou M, Xie XS, Wu T. Yang Q, et al. Cochrane Database Syst Rev. 2014 Oct 9;2014(10):CD006881. doi: 10.1002/14651858.CD006881.pub2. Cochrane Database Syst Rev. 2014. PMID: 25300168 Free PMC article. Review.
• Frequency of administration of erythropoiesis-stimulating agents for the anaemia of end-stage kidney disease in dialysis patients.
  Hahn D, Cody JD, Hodson EM. Hahn D, et al. Cochrane Database Syst Rev. 2014 May 28;2014(5):CD003895. doi: 10.1002/14651858.CD003895.pub3. Cochrane Database Syst Rev. 2014. PMID: 24872328 Free PMC article. Review.
• The role of anemia management in improving outcomes for African-Americans with chronic kidney disease.
  Lea JP, Norris K, Agodoa L. Lea JP, et al. Am J Nephrol. 2008;28(5):732-43. doi: 10.1159/000127981. Epub 2008 Apr 24. Am J Nephrol. 2008. PMID: 18434712 Free PMC article. Review.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • S. Karger AG, Basel, Switzerland

• Medical

  • MedlinePlus Health Information